Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production

Journal of Clinical Investigation

Volumn 97, Issue 11, 1996, Pages 2660-2671

  Plump, Andrew S ^a   Erickson, Sandra K ^b   Weng, Wei ^a   Partin, Jacqueline S ^c   Breslow, Jan L ^a   Williams, David L ^c  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

apolipoprotein deficient mice; corticosteroids; high density lipoprotein; selective uptake

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN E; CHOLESTEROL ESTER; CORTICOSTEROID; DEXAMETHASONE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CHOLESTEROL TRANSPORT; FEMALE; LIPOPROTEIN DEFICIENCY; MALE; MICROVILLUS; MOUSE; NONHUMAN; OVARY; PRIORITY JOURNAL; STEROIDOGENESIS; TESTIS; ZONA FASCICULATA;

EID: 0029887095     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118716     Document Type: Article

References (60)

1. Miller, G.J., and N.E. Miller. 1975. Plasma high density lipoprotein concentration and the development of ischaemic heart disease. Lancet. 1:16-19.
2. Gordon, T., W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber. 1977. High density lipoprotein as a protective factor against coronary heart disease. Am. J. Med. 62:707-714.
3. Ruben, E.M., R.M. Krauss, E.A. Spangler, J.G. Verstuyft, and S.M. Clift. 1991. Inhibition of early atherosclerosis in transgenic mice by human apolipoprotein AI. Nature (Lond.). 353:265-267.
4. Plump, A.S., C.J. Scott, and J.L. Breslow. 1994. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA. 91:9607-9611.
5. Paszty, C., N. Maeda, J. Verstuyft, and E.M. Rubin. 1994. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J. Clin. Invest. 94:899-903.
6. Liu, A.C., R.M. Lawn, J.G. Verstuyft, and E.M. Rubin. 1994. Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice. J. Lipid Res. 35:2263-2267.
7. Glomset, J.A. 1968. The plasma lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9:155-167.
8. Johnson, W.J., F.H. Mahlberg, G.H. Rothblat, and M.C. Phillips. 1991. Cholesterol transport between cells and high-density lipoproteins. Biochim. Biophys. Acta Lipids Lipid Metab. 1085:273-298.
9. Goldberg, D.I., W.F. Beltz, and R.C. Pittman. 1991. Evaluation of pathways for the cellular uptake of high density lipoprotein cholesterol esters in rabbits. J. Clin. Invest. 87:331-346.
10. Glass, C., R.C. Pittman, M. Civen, and D. Steinberg. 1985. Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro. J. Biol. Chem. 260:744-750.
11. Pittman, R.C., T.P. Knecht, M.S. Rosenbaum, and C.A. Taylor, Jr. 1987. A nonendocytotic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters. J. Biol. Chem. 262:2443-2450.
12. Glass, C., R.C. Pittman, D.B. Weinstein, and D. Steinberg. 1983. Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad. Proc. Natl. Acad. Sci. USA. 80:5435-5439.
13. Rinninger, F. and R.C. Pittman. 1988. Regulation of the selective uptake of high density lipoprotein-associated cholesteryl esters by human fibroblasts and Hep G2 hepatoma cells. J. Lipid Res. 29:1179-1194.
14. Stein, Y., Y. Dabach, G. Hollander, G. Halperin, and O. Stein. 1983. Metabolism of HDL-cholesteryl ester in the rat, studied with a nonhydrolyzable analog, cholesteryl linoleyl ether. Biochim. Biophys. Acta. 752:98-105.
15. Rinninger, F., M. Brundert, S. Jackle, P.R. Galle, C. Busch, J.R. Izbicki, X. Rogiers, D. Henne-Burns, B. Kremer, C.E. Broelsch, and H. Greten. 1994. Selective uptake of high-density lipoprotein-associated cholesteryl esters by human hepatocytes in primary culture. Hepatology. 19:1100-1119.
16. Gwynne, J.T., D. Maheffee, H.B. Brewer, Jr., and R.L. Ney. 1976. Adrenal cholesterol uptake from plasma lipoproteins: regulation by corticotropin. Proc. Natl. Acad. Sci. USA. 73:4329-4333.
17. Andersen, J.M., and J.M. Dietschy. 1978. Relative importance of high and low density lipoproteins in the regulation of cholesterol synthesis in the adrenal gland, ovary, and testis of the rat. J. Biol. Chem. 253:9024-9032.
18. Kovanen, P.T., W.J. Schneider, G.M. Hillman, J.L. Goldstein, and M.S. Brown. 1979. Separate mechanisms for the uptake of high and low density lipoproteins by mouse adrenal gland in vivo. J. Biol. Chem. 254:5498-5505.
19. Gwynne, J.T., and B. Hess. 1980. The role of high density lipoproteins in rat adrenal cholesterol metabolism and steroidogenesis. J. Biol. Chem. 255: 10875-10883.
20. Plump, A.S., T. Hayek, A. Walsh, and J.L. Breslow. 1993. Diminished HDL cholesterol ester flux in apoA-I-deficient mice. Circulation. 88:2266a. (Abstr.)
21. Weng, W., T. Hayek, and J.L. Breslow. 1995. Dramatic reduction of high density lipoprotein in apolipoprotein A-II deficient mice created by homologous recombination in ES cells. Circulation. 92:492a. (Abstr.)
22. Plump, A.S., J.D. Smith, T. Hayek, K. Aalto-Setälä, A. Walsh, J.G. Verstuyft, E.M. Rubin, and J.L. Breslow. 1992. Sever hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:343-353.
23. Smythe, G.A., J.E. Bradshaw, and R.F. Vining. 1983. Hypothalamic monoamine control of stress-induced adrenocorticotropin release in the rat. Endocrinology. 113:1062-1067.
24. Doering, C.H., J.G.M. Shire, S. Kessler, and R.B. Clayton. 1972. Cholesterol ester concentration and corticosterone production in adrenals of C57BL/ 10 and DBA/2 strains in relation to adrenal lipid depletion. Endocrinology. 90: 93-101.
25. Coalson, R.E. 1981. Staining methods for cell types in endocrine glands. In Staining Procedures. G. Clark, editor. Williams and Wilkins, Baltimore. 228-229.
26. Kowal, J., and R. Fiedler. 1968. Adrenal cells in tissue culture. I. Assay of steroid products. Arch. Biochem. Biophys. 128:406-421.
27. Erickson, S.K., S.R. Lear, M.A. Barker, and T.A. Musliner. 1990. Regulation of cholesterol metabolism in the ethionine induced premalignant rat liver. J. Lipid Res. 31:933-945.
28. Voyno-Yasenetskaya, T.A., L.G. Dobbs, S.K. Erickson, and R.L. Hamilton. 1993. Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells. Proc. Natl. Acad. Sci. USA. 90:4256-4260.
29. Havel, R.J., H.A. Eder, and J.H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1345-1353.
30. Moses, H.L., W.W. Davis, A.S. Rosenthal, and L.D. Garren. 1969. Adrenal cholesterol: localization by electron-microscope autoradiography. Science (Wash. DC). 163:1203-1205.
31. Sand, G., J. Frühling, W. Penasse, and A. Claude. 1972. Distribution du cholestérol dans la corticosurrénale du rat: analyse morphologique et chimique des fractions subcellulaires, isolées par centrifugation différentielle. J. Microsc. 15:41-66.
32. Nicosia, M., M.M. Prack, and D.L. Williams. 1992. Differential regulation of apolipoprotein E mRNA in z. fasciculata cells of rat adrenal gland determined by in situ hybridization. Mol. Endocrinol. 6:288-298.
33. Reaven, E., M. Spicher, and S. Azhar. 1989. Microvillar channels: a unique plasma membrane compartment for concentrating lipoproteins on the surface of rat adrenal cortical cells. J. Lipid Res. 30:1551-1560.
34. Blue, M.-L., D.L. Williams, S. Zucker, S.A. Khan, and C.B. Blum. 1983. Apolipoprotein E synthesis in human kidney, adrenal gland, and liver. Proc. Natl. Acad. Sci. USA. 80:283-287.
35. Williams, D.L., P.A. Dawson, T.C. Newman, and L.L. Rudel. 1985. Apolipoprotein E synthesis in peripheral tissues of nonhuman primates. J. Biol. Chem. 260:2444-2451.
36. Williams, D.L., J.S. Wong, S.L. Wissig, and R.L. Hamilton. 1995. Cell surface "blanket" of apolipoprotein E on rat adrenocortical cells. J. Lipid Res. 36:745-758.
37. Leblond, L., and Y.L. Marcel. 1993. Uptake of high density lipoprotein cholesterol ester by hepG2 cells involves apolipoprotein E localized on the cell surface. J. Biol. Chem. 268:1670-1676.
38. Leitersdorf, E., A. Israeli, O. Stein, S. Eisenberg, and Y. Stein. 1986. The role of apolipoproteins of HDL in the selective uptake of cholesteryl linoleyl ether by cultured rat and bovine adrenal cells. Biochim. Biophys. Acta. 878: 320-329.
39. Pittman, R.C., C.K. Glass, D. Atkinson, and D.M. Small. 1987. Synthetic high density lipoprotein particles. Application to studies of the apoprotein specificity for selective uptake of cholesterol esters. J. Biol. Chem. 262:2435-2442.
40. Gwynne, J.T., and D.D. Mahaffee. 1989. Rat adrenal uptake and metabolism of high density lipoprotein cholesteryl ester. J. Biol. Chem. 264:8141-8150.
41. Acton, S., A. Rigotti, K.T. Landschulz, S. Xu, H.H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor. Science (Wash. DC). 271:518-520.
42. Parks, J.S., H. Li, A.K. Gebre, T.L. Smith, and N. Maeda. 1995. Effect of apolipoprotein A-I deficiency on lecithin:cholesterol acyltransferase activation in mouse plasma. J. Lipid Res. 36:349-355.
43. Green, S.R., and R.C. Pittman. 1991. Comparative acyl specificities for transfer and selective uptake of high density lipoprotein cholesteryl esters. J. Lipid Res. 32:457-467.
44. Levine, D.M., T.S. Parker, T.M. Donnelly, A. Walsh, and A.L. Rubin. 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA. 90:12040-12044.
45. Brown, M.S., P.T. Kovanen, and J.L. Goldstein. 1979. Receptor mediated uptake of lipoprotein-cholesterol and its utilization for steroid synthesis in the adrenal cortex. Rec. Prog. Horm. Res. 35:215-257.
46. Kovanen, P.T., J.L. Goldstein, D.A. Chappell, and M.S. Brown. 1980. Regulation of low density lipoprotein receptors by adrenocorticotropin in the adrenal gland of mice and rats in vivo. J. Biol. Chem. 255:5591-5598.
47. Hoeg, J.M., L. Loriaux, R.E. Gregg, W.R. Green, and H.B.J. Brewer. 1985. Impaired adrenal reserve in the Watanabe heritable hyperlipidemic rabbit: implications for LDL-receptor function in steroidogenesis. Metab. Clin. Exp. 34:194-197.
48. Rainey, W.E., R.J. Rodgers, and J.I. Mason. 1992. The role of bovine lipoproteins in the regulation of steroidogenesis and HMG-CoA reductase in bovine adrenocortical cells. Steroids. 57:167-173.
49. Durand, P., A.M. Cathiard, E. Naaman, V. Brieu, and J.M. Saez. 1987. The influence of plasma lipoproteins on steroidogenesis of cultured ovine fetal and neonatal adrenal cells. J Steroid Biochem. 26:425-431.
50. Higashijima, M., K. Kato, H. Nawata, and H. Ibayashi. 1987. Studies on lipoprotein and adrenal steroidogenesis. II. Utilization of low density lipoprotein- and high density lipoprotein-cholesterol for steroid production in functioning human adrenocortical adenoma cells in culture. Endocrinol Jpn. 34: 647-657.
51. Higashijima, M., H. Nawata, K. Kato, and H. Ihayashi. 1987. Studies on lipoprotein and adrenal steroidogenesis. I. Roles of low density lipoprotein-and high density lipoprotein-cholesterol in steroid production in cultured human adrenocortical cells. Endocrinol. Jpn. 34:635-645.
52. Carr, R.R., and E.R. Simpson. 1981. Lipoprotein utilization and cholesterol synthesis by the human fetal adrenal gland. Endocr. Rev. 2:306-326.
53. Goldstein, J.L., S.K. Basu, and M.S. Brown. 1983. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98: 241-260.
54. Laue, L., J.M. Hoeg, K, Barnes, D.L. Loriaux, and G.P. Chrousos. 1987. The effect of mevinolin on steroidogenesis in patients with defects in the low density lipoprotein receptor pathway. J. Clin. Endocrinol & Metab. 64:531-535.
55. Boizel, R., E. de Peretti, A.M. Cathiard, S. Halimi, M. Bost, F. Berthezene, and J.M. Saez. 1986. Pattern of plasma levels of cortisol, dehydoepiandrosterone and pregnenolone sulphate in normal subjects and in patients with homozygous familial hypercholesterolemia during ACTH infusion. Clin. Endocrinol. 25:363-371.
56. Allen, J.M., G.R. Thompson, and N.B. Myant. 1983. Normal adrenocortical response to adrenocorticotrophic hormone in patients with homozygous familial hypercholesterolemia. Clin. Sci. 65:99-101.
57. Illingworth, D.R., E.S. Orwoll, and W.E. Connor. 1980. Impaired cortisol secretion in abetalipoproteinemia. J. Clin. Endocrinol & Metab. 50:977-979.
58. Illingworth, D.R., T.A. Kenny, and E.S. Orwoll. 1982. Adrenal function in heterozygous and homozygous hypobetalipoproteinemia. J. Clin. Endocrinol. & Metab. 54:27-33.
59. Prack, M.M., M. Nicosia, D.L. Williams, and J. Gwynne. 1991. Relationship between apolipoprotein E mRNA expression and tissue cholesterol content in rat adrenal gland. J. Lipid Res. 32:1611-1618.
60. Prack, M.M., G.H. Rothblat, S.K. Erickson, M.E. Reyland, and D.L. Williams. 1994. Apolipoprotein E expression in Y1 adrenal cells is associated with increased intracellular cholesterol content and reduced free cholesterol efflux. Biochemistry. 33:5049-5055.